Giles Day - Site Director, Distributed Bio - Charles River Laboratories | LinkedIn
Charles River teams with Distributed Bio to advance antibody discovery platform
Charles River teams with Distributed Bio to advance antibody discovery platform
Distributed Bio Company Profile: Acquisition & Investors | PitchBook
Charles River Labs Acquires Antibody Partner Distributed Bio for Up to $104M
Phage Antibody Discovery and Antibody Engineering | Charles River
Charles River Laboratories Acquires Distributed Bio | Business Wire
Charles River Labs on Twitter: "We are pleased to announce the full integration of Cognate BioServices, Cobra Biologics, Vigene Biosciences, Hemacare, Cellero, Distributed Bio, Retrogenix into Charles River. Learn about our end-to-end
Charles River Laboratories: Medium-Term Outlook Strong, But Overvalued (NYSE:CRL) | Seeking Alpha
Charles River and Distributed Bio enter exclusive partnership
A New Way to Target GPCRs | Charles River
Charles River Acquired Distributed Bio – Here's What it Means for the AI Ecosystem - Emersion Insights
Charles River Labs Acquires Antibody Partner Distributed Bio for Up to $104M
Deal sees Charles River Labs acquire large-molecule discovery platform
Charles River teams with Distributed Bio to advance antibody discovery platform
Partnership with Distributed Bio Enables End-to-End Platform for Therapeutic Antibody Discovery & Development | Charles River
Charles River Laboratories spends $83M to snap up Distributed Bio to boost antibody work | Fierce Biotech
Sarah Ives on Instagram: “We sold the company!! Distributed Bio is now owned by Charles River Labs. We are excited to join this fantastic organization, which works…”
Meet the Antibody Discovery Team | Charles River
Charles River Acquired Distributed Bio | Charles River
